Status:
COMPLETED
Predictive Value of Bio-impedance Vector Analysis on Long-term Outcome in ICU Patients
Lead Sponsor:
Frisius Medisch Centrum
Conditions:
Long-term Outcome
Survival
Eligibility:
All Genders
18+ years
Brief Summary
Phase angle, derived from bioimpedance analysis (BIA), reflects tissue quality and quantity in which cell mass, membrane integrity and hydration state are represented. Phase angle, as a measure of bod...
Detailed Description
Phase angle, derived from bioimpedance analysis (BIA), reflects tissue quality and quantity in which cell mass, membrane integrity and hydration state are represented. Phase angle, as a measure of bod...
Eligibility Criteria
Inclusion
- all patients admitted to the ICU, elective and acute.
Exclusion
- age below 18
- Length of stay at ICU \< 6 hours
- All invalid bio-impedence analysis (BIA) measurements
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
1025 Patients enrolled
Trial Details
Trial ID
NCT04449796
Start Date
June 1 2018
End Date
June 1 2020
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Centre Leeuwarden - Intensive Care Unit
Leeuwarden, Netherlands, 8901 BR